(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Explosions at Burundi ammunition depot kill civilians, witnesses say - 2Environmental groups urge Germany to cut oil and gas dependence
- 3Looter indicted after pretending to be emergency worker at Dimona rocket crash site
- 4People Are Sharing The One Picture They Can't See Without Laughing, And It's The Comedy Spiral You Need Today
- 5Exploring Asia’s Realm of Flying Snakes
- Man triggers smoke bomb during failed crypto robbery
- Emergent Cold LatAm opens state-of-the-art cold storage hub in Guadalajara
- How AI fixed the James Webb Space Telescope's blurry vision
- Most loved Amusement Park for Small children: Which One Do You Suggest?
- Christopher Nolan's 'The Odyssey' trailer: See Anne Hathaway, Matt Damon and Tom Holland in 1st look at movie
- WATCH: IDF strikes, dismantles missile launchers in southern Lebanon
- How does Spotify Wrapped calculate your listening age? What your number says about you.
- Geomagnetic storm grounds launch of Mars space weather satellites
- Nestlé recalls infant formula in 49 countries. See list.
